Search results
Moderna and Novavax Hope for Early Launch of This Year’s Covid-19 Shots, Despite FDA Delay
Barrons.com· 7 days agoVaccine makers Moderna and Novavax are hoping for an August rollout this year, earlier than last...
Should You Buy This Stock After a Regulatory Setback?
The Motley Fool via AOL· 22 hours agoModerna's mRNA vaccine platform proved its value in the coronavirus market. The company has many...
New Covid FLiRT Variants Have the FDA Weighing a Vaccine Update
Bloomberg· 4 days agoGood morning! It’s Jessica in New York. A new Covid variant is forcing the FDA to reevaluate...
Free COVID-19 vaccines could be a thing of the past. Experts weigh in.
USA TODAY via Yahoo News· 5 days agoS., David Daigle, a Centers...vaccines were accessible for uninsured and underinsured patients. ...
Why Vaccine Stocks Rallied This Week
Motley Fool via Yahoo Finance· 3 days agoShould you invest $1,000 in Moderna right now? Before you buy stock in Moderna, consider...follow blueprint for success, including guidance on building...
Evolving With the Virus: Repeat COVID-19 Shots Neutralizing Beyond the Expected
SciTechDaily· 4 days agoDue to the virus’s remarkable capacity for mutation and immune evasion, the World Health...
Misleading Claims on Well-Known Rare Risk of AstraZeneca COVID-19 Vaccine - FactCheck.org
FactCheck.org· 4 days agoA rare risk of dangerous blood clots associated with the AstraZeneca COVID-19 vaccine was identified and reported in early 2021. This ...
Novavax awaits FDA decision on whether its next COVID shot can be offered in US
StreetInsider· 2 days agoThe European Union's regulator told vaccine makers last month to update their vaccines for that variant because they ...
Could current COVID vaccines protect against future outbreaks? New study offers hope
Orange County Register· 4 days agoA group of researchers had the future in mind when they asked if current COVID-19 vaccines and...
Iran's new president's link to COVID vaccine
Newsweek· 7 days agoNew interim Iranian President Mohammad Mokhber received scrutiny for his role in the lack of development of a domestic vaccine at the height of the COVID